Citation:Future II Study Group, Ault KA 2007
From National Cancer Control Policy
Future II Study Group, Ault KA. Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials. Lancet 2007 Jun 2;369(9576):1861-8 Available from: http://www.ncbi.nlm.nih.gov/pubmed/17544766.
Critical appraisals